Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1988;8:40-45

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostlund-Lindqvist, A. M.
Right arrow Articles by Nordborg, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostlund-Lindqvist, A. M.
Right arrow Articles by Nordborg, C.

Arteriosclerosis, Vol 8, 40-45, Copyright © 1988 by American Heart Association


ARTICLES

Effect of metoprolol on diet-induced atherosclerosis in rabbits

AM Ostlund-Lindqvist, P Lindqvist, J Brautigam, G Olsson, G Bondjers and C Nordborg
Department of Pharmacology and Biochemistry, Hassle Research Laboratories, Molndal, Sweden.

The effect of metoprolol, a beta 1-blocker, on atherogenesis was evaluated in rabbits fed a diet supplemented with 0.25% cholesterol and 3% coconut oil for 21 weeks. After 7 weeks on the diet, the rabbits were randomly divided into treated (n = 22) and untreated (n = 22) groups. Treated animals received metoprolol subcutaneously by an osmotic pump for 14 weeks, resulting in a plasma level of 774 +/- 69 nM during the investigation. Plasma concentrations of cholesterol, triglycerides, and phospholipids did not differ between the two groups. Nor were there any significant differences between the two groups in plasma concentrations of apolipoprotein A-I, apolipoprotein B, apolipoprotein C-III, and apolipoprotein E measured by electroimmunoassay. At the end of the study, the aortas were cut into three portions and the extent of atherosclerosis was determined by morphometry. The group that had received metoprolol had significantly (p less than 0.015) less atherosclerosis in the aorta (ascending plus arch 37.8 +/- 6.8%, thoracic 32.9 +/- 6.1%, abdominal 19.8 +/- 6.1% of total intimal area; mean +/- SEM) than the controls (ascending plus arch 54.9 +/- 7.1%, thoracic 48.0 +/- 6.2%, abdominal 25.9 +/- 5.5%).


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
I. Sipahi, E. M. Tuzcu, K. E. Wolski, S. J. Nicholls, P. Schoenhagen, B. Hu, C. Balog, M. Shishehbor, W. A. Magyar, T. D. Crowe, et al.
{beta}-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials
Ann Intern Med, July 3, 2007; 147(1): 10 - 18.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
O. Wiklund, J. Hulthe, J. Wikstrand, C. Schmidt, S.-O. Olofsson, and G. Bondjers
Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia: A 3-Year Randomized Study
Stroke, February 1, 2002; 33(2): 572 - 577.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Hedblad, J. Wikstrand, L. Janzon, H. Wedel, and G. Berglund
Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness : Main Results From the {beta}-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)
Circulation, April 3, 2001; 103(13): 1721 - 1726.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Wikstrand, I. Warnold, G. Olsson, J. Tuomilehto, D. Elmfeldt, G. Berglund, the Advisory Committee, G. Olsson, J. Tuomilehto, I. Warnold, et al.
Primary Prevention With Metoprolol in Patients With Hypertension: Mortality Results From the MAPHY Study
JAMA, April 1, 1988; 259(13): 1976 - 1982.
[Abstract] [PDF]